Profiling Laboratory Biomarkers Associated with COVID19 Disease Progression: A Single‐Center Experience

M Khan, N Shah, H Mushtaq… - International Journal of …, 2021 - Wiley Online Library
… linked with the severity of COVID-19 [9]. Notably, increasing serum CRP levels corresponded
to disease progression, serving as an early predictor for COVID-19 complication, prior to …

Laboratory biomarkers of COVID-19 disease severity and outcome: Findings from a developing country

TW Leulseged, IS Hassen, BT Ayele, YG Tsegay… - PloS one, 2021 - journals.plos.org
COVID-19 disease severity and outcome among 429 COVID-19 patients who were admitted
to Millennium COVID-19 … Timely identification of biomarkers of COVID-19 disease severity …

Low levels of few micronutrients may impact COVID-19 disease progression: an observational study on the first wave

TM Tomasa-Irriguible, L Bielsa-Berrocal… - Metabolites, 2021 - mdpi.com
We report an observational study performed between March and May 2020 in a Spanish
university hospital during the SARS-CoV-2 pandemic. The main objective was to analyse the …

Immune suppression in the early stage of COVID-19 disease

W Tian, N Zhang, R Jin, Y Feng, S Wang, S Gao… - Nature …, 2020 - nature.com
… We subdivided the 14 COVID-19 patients into nine with moderate disease type and five with
severe disease type according to the information provided by the attending physicians at the …

Simulating the progression of the COVID-19 disease in Cameroon using SIR models

U Nguemdjo, F Meno, A Dongfack, B Ventelou - PLoS One, 2020 - journals.plos.org
This paper analyses the evolution of COVID-19 in Cameroon over the period March 6–April
2020 using SIR models. Specifically, we 1) evaluate the basic reproduction number of the …

Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study

J Tian, X Yuan, J Xiao, Q Zhong, C Yang, B Liu… - The Lancet …, 2020 - thelancet.com
… determine risk factors of COVID-19 disease severity for patients with cancer and COVID-19. …
We found that the odds of COVID-19 progressing into severe illness was 3·611 times higher …

Significant unresolved questions and opportunities for bioengineering in understanding and treating COVID-19 disease progression

J Shirazi, MJ Donzanti, KM Nelson… - Cellular and Molecular …, 2020 - Springer
… can be employed to help understand COVID-19. The use of sophisticated in vitro … and
COVID-19 progression. Application of advanced tissue and organ system models into COVID-19

MuLBSTA score is a useful tool for predicting COVID-19 disease behavior

Y Iijima, T Okamoto, T Shirai, T Mitsumura… - Journal of Infection and …, 2021 - Elsevier
… , including coronavirus, but the scoring system has not been verified in novel coronavirus
this scoring system for estimating the risk of disease worsening in patients with COVID-19. …

COVID-19: staging of a new disease

C Cordon-Cardo, E Pujadas, A Wajnberg, R Sebra… - Cancer Cell, 2020 - cell.com
… to or present with a severe phase of the disease, requiring … progression toward stage 4.
Neutrophils and macrophages have emerged as key players in COVID-19 disease progression. …

SnoRNAs and miRNAs networks underlying COVID-19 disease severity

A Parray, FA Mir, A Doudin, A Iskandarani… - Vaccines, 2021 - mdpi.com
… the peripheral blood of severe COVID-19 cases (n = 9), as compared to mild (n = 10) and
asymptomatic (n = 10) patients. This study analyzed a total of 29 COVID-19 patients that were …